49,267
edits
(→Molecular: +table) |
(→Molecular: more) |
||
| Line 21: | Line 21: | ||
===Tests=== | ===Tests=== | ||
Hereditary: | |||
{| class="wikitable sortable" style="margin-left:auto;margin-right:auto" | {| class="wikitable sortable" style="margin-left:auto;margin-right:auto" | ||
! Target | ! Target | ||
! Technique | ! Technique | ||
! Disease | ! Disease | ||
! Notes | |||
|- | |- | ||
| F2<ref>{{OMIM|176930}}</ref> | | F2<ref>{{OMIM|176930}}</ref> | ||
| PCR | | PCR | ||
| thrombophilia | | thrombophilia | ||
| see ''[[Pulmonary_embolism#Risks_factors_.28VTE.29|Risks for VTE]]'' | |||
|- | |||
| F5<ref>{{OMIM|612309}}</ref> | |||
| PCR | |||
| thrombophilia | |||
| see ''[[Pulmonary_embolism#Risks_factors_.28VTE.29|Risks for VTE]]'' | |||
|- | |||
| HFE<ref>{{OMIM|613609}}</ref> Cys282Tyr, His63Asp | |||
| PCR | |||
| [[hemochromatosis]] | |||
| - | |||
|- | |||
| | |||
| | |||
| Malignant hyperthermia | |||
| anesthetics | |||
|- | |- | ||
| | | | ||
| | | | ||
| | | Herediary [[amyloidosis]] | ||
| | |||
|- | |||
| | |||
| | |||
| Alpha thalassemia | |||
| | |||
|} | |} | ||
[[Lymphoma]]: | |||
*Follicular lymphoma vs. follicular hyperplasia (BCL2). | |||
*T cell neoplasia. | |||
*B cell neoplasia. | |||
*PTLPD vs. rejection. | |||
*HHV associated lymphomas. | |||
Leukemia: | |||
*Several. | |||
Carcinoma: | |||
*Nasopharyngeal (EBV quantitation). | |||
*HPV testing. | |||
*Metastatic [[colorectal carinoma]]. | |||
* | *Non small cell [[lung cancer]]. | ||
*Papillary thyroid carcinoma. | |||
Other: | |||
*Oligodendroglioma. | |||
*Identity testing (15 STRs and amelogenin (XY) loci). | |||
*Melanoma (KIT, BRAF). | |||
*[[Synovial sarcoma]]. | |||
*Myeloproliferative disorders. | |||
*AML, mastocytosis, GIST. | |||
==Cytogenetics== | ==Cytogenetics== | ||
edits